# Treatment of Post-radiation Xerostomia With Allogeneic Mesenchymal Stromal Stem Cells

> **NCT06012604** · PHASE1 · UNKNOWN · sponsor: **Institute of Oncology Ljubljana** · enrollment: 20 (estimated)

## Conditions studied

- Xerostomia Following Radiotherapy

## Interventions

- **BIOLOGICAL:** allogeneic mesenchymal stromal stem cells

## Key facts

- **NCT ID:** NCT06012604
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-08-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06012604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06012604, "Treatment of Post-radiation Xerostomia With Allogeneic Mesenchymal Stromal Stem Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06012604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*